These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22193145)

  • 61. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of hormone therapy in the management of menopause.
    Shifren JL; Schiff I
    Obstet Gynecol; 2010 Apr; 115(4):839-855. PubMed ID: 20308847
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 65. American College of Preventive Medicine Practice Policy Statement: perimenopausal and postmenopausal hormone replacement therapy.
    Nawaz H; Katz DL
    Am J Prev Med; 1999 Oct; 17(3):250-4. PubMed ID: 10987643
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Hormone replacement therapy and endometrial cancer].
    Concin H; Sommerlechner M
    Gynakol Geburtshilfliche Rundsch; 1998; 38(2):93-5. PubMed ID: 9815525
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reducing the problems of the progestogen.
    Sturdee DW; MacLennan AH
    Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653
    [No Abstract]   [Full Text] [Related]  

  • 68. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Negative Women's Health Initiative findings stir consternation, debate among researchers.
    Twombly R
    J Natl Cancer Inst; 2006 Apr; 98(8):508-10. PubMed ID: 16622115
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Jan; 35(1):1-16. PubMed ID: 7751408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS.
    Harman SM
    Gend Med; 2006 Dec; 3(4):254-69. PubMed ID: 17582367
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW; Birkhäuser M; Brincat MP; Gambacciani M; Genazzani AR; Limpaphayom KK; O'Neill S; Palacios S; Pines A; Siseles N; Tan D; Burger HG;
    Climacteric; 2004 Dec; 7(4):333-7. PubMed ID: 15799604
    [No Abstract]   [Full Text] [Related]  

  • 73. Menopause in CKD.
    Vellanki K; Hou S
    Am J Kidney Dis; 2018 May; 71(5):710-719. PubMed ID: 29530509
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases.
    Barrett-Connor E
    Am J Med; 1993 Nov; 95(5A):40S-43S. PubMed ID: 8256794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.
    Komm BS; Morgenstern D; A Yamamoto L; Jenkins SN
    Expert Rev Clin Pharmacol; 2015; 8(6):769-84. PubMed ID: 26482902
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Approach of menopause in women at risk for breast cancer].
    This P; Cormier C
    Gynecol Obstet Fertil; 2002 Feb; 30(2):101-13. PubMed ID: 11910878
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 78. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.
    Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP; Petak SM
    Endocr Pract; 2010; 16(6):1016-9. PubMed ID: 21216723
    [No Abstract]   [Full Text] [Related]  

  • 79. [Menopausal hormonal therapy and cancer risks].
    Lasserre A; Fournier A
    Gynecol Obstet Fertil; 2016; 44(7-8):424-7. PubMed ID: 27451070
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.